Implicit ethical choices in ultra-rare therapy development: researchers’ perspectives on patient selection and communication, therapy value, and accessibility

Mariia V. Maksimova, Rosan L. Lechner, Felicia V.Y.L. Lee-Kong, Johannes J.M. van Delden, Ghislaine J.M.W. van Thiel · 2026

Read Implicit ethical choices in ultra-rare therapy development: researchers’ perspectives on patient selection and communication, therapy value, and accessibility by Mariia V. Maksimova, Rosan L. Lechner, Felicia V.Y.L. Lee-Kong, Johannes J.M. van Delden, Ghislaine J.M.W. van Thiel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13361119.txt.

Description

Mariia Maksimova, Rosan Lechner, Felicia Lee-Kong, Johannes van Delden, and Ghislaine van Thiel interview makers of ultra-rare disease therapies in this 2026 study. These one patient treatments are feats of technology, yet every early choice, which disease, which patient, what counts as success, carries hidden ethical weight.

Fifteen researchers building a shared platform for personalized RNA therapies described their practice. Patient picking felt technical to them, and they favored committees and algorithms to keep emotion out. Talking with families felt fragile, shadowed by false hope. Views of a therapy's worth ranged from easing symptoms to doubting the effort was justified. Access barriers registered as landscape, not personal duty. Naming these choices, the authors argue, makes development fairer.

Catalog record

CREATORMariia V. Maksimova, Rosan L. Lechner, Felicia V.Y.L. Lee-Kong, Johannes J.M. van Delden, Ghislaine J.M.W. van Thiel
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13361119

Browse the full library · About the Tower of Babel